Replies to post #173515 on Biotech Values

[DewDiligence]

Amusing ORMP factoid from exposé in The New York Observer:

http://observer.com/2014/02/tough-to-swallow-paper-trail-behind-breakthrough-leads-to-penny-stock-profiteers/

[Oramed] has spent a total of just $12 million in cumulative R&D since 2002 [!]. Novo Nordisk spent $635 million on R&D in the fourth quarter of 2013 alone.